Natriuretic peptides (NPs) promote diuresis, natriuresis and vasodilation in early chronic
heart failure (CHF), countering renin–angiotensin–aldosterone system (RAAS) and …

The natriuretic peptide family consists of at least 3 structurally similar peptides: atrial
natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide …

Aim This study aimed at evaluating the effects of sacubitril/valsartan on neprilysin (NEP),
and the metabolism of natriuretic peptides in heart failure (HF) and providing additional …

Background Patients with congestive heart failure (CHF) have high plasma levels of atrial
natriuretic peptide (ANP), mainly from the atrium, and brain natriuretic peptide (BNP), mainly …

After its discovery in the early 1980s, the natriuretic peptide (NP) system has been
extensively characterized and its potential influence in the development and progression of …

A hallmark of congestive heart failure (CHF) is the activation of the cardiac endocrine
system, in particular atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP). The …

Atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) are secreted by the
heart and play important roles in the compensation of congestive heart failure with their …

Natriuretic peptides, which are activated in heart failure, play an important cardioprotective
role. The most notable of the cardioprotective natriuretic peptides are atrial natriuretic …

The current standard treatment of chronic heart failure (HF) is based on clinical judgment,
with the goal of achieving the maximally tolerated therapeutic program. The complexity of …

BACKGROUND Atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type
natriuretic peptide (CNP) are a family of structurally related peptides that participate in the …